BioSpace News Archive

Deals

CONMED Corporation Announces Annual Meeting of Shareholders

CONMED Corporation announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019, at 3:30 p.m. ET.

March 12, 2019
·
2 min read
Business

Corindus Reports Fourth Quarter and Full Year 2018 Results

Submitted Neurovascular Indication Marking Important Step toward Addressing Stroke Market; Raised $19.8 Million to Fund Ongoing Innovation

March 12, 2019
·
11 min read
Deals

Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted against cancers and infectious diseases, reported financial results for the fourth quarter and year ended December 31, 2018.

March 12, 2019
·
17 min read
Deals

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, reported financial results for the fourth quarter and full year ended December 31, 2018.

March 12, 2019
·
9 min read
Biotech Beach

International Glaucoma Study Confirms Long-term Efficacy and Safety Profile of Glaukos iStent® Implantation in Combination with Cataract Surgery

At 5 Years Postoperative, Mean IOP Decreased 38% to 14.7 mmHg and Topical Ocular Hypotensive Medication Use Declined 75% while Safety Profile Remained Favorable

March 12, 2019
·
10 min read
Biotech Bay

NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy

Makes board and executive changes and reduces U.S. sales organization to focus only on high-performing, high potential sales territories and specialty pharmacy channel expansion

March 12, 2019
·
6 min read
Business

Vapotherm Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Vapotherm, Inc., a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced today fourth quarter and fiscal year 2018 financial results.

March 12, 2019
·
21 min read
Business

Statement from the Chief Public Health Officer of Canada, Dr. Theresa Tam, on the current measles outbreak and vaccine hesitancy

As Canada’s Chief Public Health Officer, I am very concerned to see vaccine-preventable diseases, particularly those as serious and highly contagious as measles, making a comeback in Canada and around the globe.

March 12, 2019
·
2 min read
Policy

Janssen Submits Application to U.S. FDA Seeking Approval of DARZALEX® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible

Application supported by the Phase 3 MAIA study being reviewed under the FDA Real-Time Oncology Review pilot program

March 12, 2019
·
20 min read
Business

Rafael Holdings Reports Second Quarter Fiscal Year 2019 Results

Rafael Holdings, Inc., reported revenue of $1.0 million and a loss per share of $0.08 for the second quarter of its 2019 fiscal year, the three months ended January 31, 2019.

March 12, 2019
·
7 min read